Speaker illustration

Doctor Soumaya Ben-Aicha

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Dr. Ben-Aicha obtained her PhD from the University of Barcelona, with her research centered on the influence of hypercholesterolemia on coronary artery disease and myocardial infarction in large-animal models, specifically examining the effects on HDLs. she also worked on the pleiotropic effects of statin treatment, resulting in intellectual property, and numerous publications where she served as a first or co-author. She further investigated the impact of statins on cardiovascular rhythm in Germany. Subsequently, she joined Imperial College London (ICL), supported by the British Heart Foundation (BHF). Recognized for her contributions, she was granted the prestigious Centre of Excellence Fellowship by the BHF, advancing to become a transition research fellow. Her main focus lies in atherosclerosis prevention, with a particular interest in the interaction between human-derived nanoparticles, macrophages and immune cells in pre-clinical and clinical settings, aiming for therapeutics.

Human macrophages are immunoprofiled by pericardial fluid small extracellular vesicles modulating lipid metabolism mechanisms.

Event: ESC Congress 2022

Topic: Microvesicles, Exosomes

Session: Targeting lipids and lipid-related pathways in cardiovascular disease

Thumbnail

Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular immune response in coronary artery disease

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Microvesicles, Exosomes

Session: Moderated poster 1 AWARD

Thumbnail

Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular myocardium-epicardium crosstalk in coronary artery disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Microvesicles, Exosomes

Session: Basic science e-posters

Thumbnail

Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology

Session: Risk Factors and Prevention ePosters

Thumbnail

Hypercholesterolemia changes HDL-miRNA signature and enhances HDL-miR126-3p and -5p delivery to endothelial cells modulating genes involved in vascular health

Event: Frontiers in CardioVascular Biology 2018

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Young Investigator Award session - Vascular

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb